Ueda, Y., Igishi, T., Hashimoto, K., Suyama, H., Araki, K., Sumikawa, T., Takeda, K., Nakazaki, H., Matsunami, K., Kodani, M., Shigeoka, Y., Matsumoto, S. and Shimizu, E. (2009) Synergistic Cell Growth Inhibition by the Combination of Amrubicin and Akt-Suppressing Tyrosine Kinase Inhibitors in Small Cell Lung Cancer Cells: Implication of c-Src and Its Inhibitor. International Journal of Oncology, 34, 689-696.

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.